Verquvo 10mg Tablet 14's

Verquvo 10mg Tablet contains Vericiguat (10mg), a soluble guanylate cyclase (sGC) stimulator used to treat chronic heart failure in adults. It helps reduce the risk of cardiovascular death and hospitalisation due to worsening heart failure symptoms.

Benefits

Verquvo 10mg Tablet works by stimulating a protein in the body called soluble guanylate cyclase (sGC). This action relaxes blood vessels, improving blood flow and making it easier for the heart to pump blood effectively. It is particularly beneficial for patients who have recently experienced a worsening heart failure event, such as hospitalisation or the need for intravenous diuretics.

Uses and Indications

• Treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction (less than 45%).
• Reduces the risk of cardiovascular death and heart failure hospitalisation following a recent worsening heart failure event.

The Verquvo 10mg Tablet contains:

• Vericiguat 10 mg (active ingredient).
• Inactive ingredients include microcrystalline cellulose, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, and sodium lauryl sulfate. The film coating contains hypromellose, talc, titanium dioxide, and ferric oxide yellow.

Dosage and Administration

1. Take one tablet once daily with food.
2. The typical starting dose is 2.5 mg once daily, which your doctor may gradually increase approximately every two weeks to a target maintenance dose of 10 mg once daily, as tolerated.
3. Swallow the tablet whole. If you have difficulty swallowing, the tablet may be crushed and mixed with water immediately before administration.
4. If a dose is missed, take it as soon as you remember on the same day. Do not take two doses on the same day to make up for a missed dose.

Storage and Disposal

• Store at room temperature, between 20°C to 25°C (68°F to 77°F). Do not store above 30°C.
• Keep this medicine out of the sight and reach of children.
• Do not dispose of medicines via wastewater or household waste; consult your pharmacist for proper disposal methods.

Precautions and Safety

• Verquvo 10mg Tablet may cause birth defects. Females of reproductive potential must have a negative pregnancy test before starting treatment and use effective contraception during treatment and for one month after stopping.
• Do not take this medicine if you are also using other soluble guanylate cyclase (sGC) stimulators, such as riociguat.
• Concomitant use with phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil, tadalafil) is not recommended due to the potential for increased low blood pressure.
• Exercise caution if you have low blood pressure, severe kidney problems, or severe liver problems.
• This medicine may cause dizziness; avoid driving or operating machinery until you know how it affects you.
• Not recommended for use during breastfeeding.

Side Effects and Risks

• Common side effects include low blood pressure (hypotension), which may cause dizziness, lightheadedness, or weakness.
• Anemia (low red blood cell count) is another common side effect, potentially leading to unusual tiredness, pale skin, or shortness of breath.
• Seek immediate medical attention if you experience signs of a serious allergic reaction, such as rash, itching, hives, or swelling of the face, lips, tongue, or throat.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.